Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information

Clinical Cancer Research

Volumn 2, Issue 7, 1996, Pages 1155-1161

  Shinozaki, Hiroharu ^a   Ozawa, Soji ^a   Ando, Nobutoshi ^a   Tsuruta, Hiroyuki ^b   Terada, Masaaki ^b   Ueda, Masakazu ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; FEMALE; GENE AMPLIFICATION; GENETIC ORGANIZATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; ESOPHAGEAL NEOPLASMS; FEMALE; GENE AMPLIFICATION; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 0029888123     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. International Union Against Cancer TNM Classification of Malignant Tumors, 4th ed. New York: Springer-Verlag, 1987.
2. Kato, H., Tachimori, Y., Watanabe, H., Iizuka, T., Terui, S., Itabashi, M , and Hirota, T. Lymph node metastasis in thoracic esophageal carcinoma. J. Surg. Oncol., 48: 106-111, 1991.
3. Kato, H., Tachimori, Y., Watanabe, H., and Iizuka, T. Evaluation of the new (1987) TNM classification for thoracic esophageal tumors. Int. J. Cancer, 53: 220-223, 1993.
4. Fahn, H-J., Wang, L-S., Huang, B-S., Huang, M-H., and Chien, K-Y. Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus. Ann. Thorac Surg., 57: 677-681, 1994.
5. Suita, S., Zaizen, Y., Kaneko, M., Uchino, J., Takeda, T., Iwafuchi, M., Utsumi, J., Takahashi, H., Yokoyama, J., Nishihira, H., Okada, A., Kawa, K., Nagahara, N., Yano, H., and Tsuchida, Y. What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese study group for the treatment of advanced neuroblastoma. J. Pediatr. Surg., 29: 746-750, 1994.
6. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K Y , and Hammond, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl. J. Med., 313: 1111-1116, 1985.
7. Nakagawara, A., Ikeda, K., Tsuda, T , and Higashi, K. N-myc oncogene amplification and prognostic factors of neuroblastoma in children. J. Pediatr. Surg., 22: 895-898, 1987.
8. Kitagawa, Y., Ueda, M., Ando, N., Shinozawa, Y., Shimizu, N., and Abe, O. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res , 51: 1504-1508, 1991.
9. Tsuda, T., Tahara, E., Kajiyama. G., Sakamoto, H., Terada, M., and Sugimura, T. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Cancer Res., 49: 5505-5508, 1989.
10. Wagata, T , Ishizaki, K., Imamura, M., Shimada, Y., Ikenaga, M., and Tobe, T Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. Cancer Res., 51: 2113-2117, 1991.
11. Berenson, J. R., Yang, J., and Mickel, R. A. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene, 4: 1111-1116, 1989
12. Faust, J. B., and Meeker, T. C. Amplification and expression of bcl-1 gene in human solid tumor cell lines. Cancer Res., 52: 2460-2463, 1992.
13. Tsuruta, H., Sakamoto, H., Onda, M., and Terada, M. Amplification and overexpression of EXP1 and EXP2/cyclin D1 genes in human esophageal carcinomas. Biochem. Biophys. Res. Commun., 196: 1529-1536, 1993.
14. Motokura, T., Bloom, T., Kim, H. G., Juppner, H., Ruderman, J. V., Kronenberg, H. M., and Arnold, A A novel cyclin encoded by a bell-linked candidate oncogene. Nature (Lond.), 350: 512-515, 1991.
15. Xiong, Y., Connolly, T., Futcher, B., and Beach, D. Human D-type cyclin. Cell, 65: 691-699, 1991.
16. Withers, D. A., Harvey, R C., Faust, J. B , Melnyk, O , Carey, K., and Meeker, T. C Characterization of a candidate bcl-1 gene. Mol. Cell. Biol., 11: 4846-4853, 1991.
17. 1 phase of the cell cycle Cell, 65: 701-713, 1991.
18. Hunter, T., and Pines, J. Cyclins and cancer. Cell, 66: 1071-1074, 1991
19. Kato, J., Matsushime, H., Hiebert, S. W., Ewem, M. E., and Sherr, C. J Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev., 7: 331-342, 1993.
20. Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., and Weinberg, R. A. Physical interaction of the retinoblastoma protein with human D cyclins. Cell, 73: 499-511, 1993.
21. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
22. Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A , and Schmidt, E. V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond.), 369: 669-671, 1994.
23. Hinds, P. W., Dowdy, S. F., Eaton, E. N., Arnold, A., and Weinberg, R. A. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA, 91: 709-713, 1994.
24. Lovec, H., Sewing, A., Lucibello, F. C., Müller, R., and Möröy, T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene, 9: 323-326, 1994.
25. Jiang, W., Kahn, S. M., Zhou, P., Zhang, Y-J., Cacace, A. M., Infante, A. S., Doi, S., Santella, R. M., and Weinstein, I. B. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8: 3447-3457,1993.
26. 1 phase in rodent fibroblasts. Genes Dev., 7: 1559-1571, 1993.
27. Asano, K., Sakamoto, H., Sasaki, H., Ochiya, T., Yoshida, T., Ohishi, Y., Machida, T., Kakizoe, T , Sugimura, T., and Terada, M. Tumongenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells. Biochem. Biophys. Res. Commun., 217: 1169-1176, 1995.
28. Kanda, Y., Nishiyama, Y., Shimada, Y., Imamura, M., Nomura, H., Hiai, H., and Fukumoto, M. Analysis of gene amplification and overexpression in human esophageal-carcinoma cell lines. Int. J. Cancer, 58: 291-297, 1994.
29. Jiang, W., Zhang, Y-J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S-H., Harris, C. C., Montesano, R., and Weinstein, I. B. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 90: 9026-9030, 1993
30. Japanese Society for Esophageal Diseases. Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus, 8th ed. Tokyo, Japan: Kanehara & Co., Ltd., 1992.
31. Dubeau, L., Chandler, L. A., Gralow, J. R., Nichols, P. W., and Jones, P. A. Southern blot analysis of DNA extracted from formalin-fixed pathology specimens. Cancer Res., 46: 2964-2969, 1986.
32. Goelz, S. E., Hamilton, S. R., and Vogelstein, B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem. Biophys. Res. Commun., 130: 118-126, 1985.
33. 2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TagI RFLP. Am. J. Hum. Genet., 45: 778-785, 1989.
34. Gramlich, T. L., Fritsch., C. R., Maurer, D., Eberle, M., and Gansler, T. S. Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma. Diagn. Mol. Pathol., 3: 255-259, 1994.
35. Adelaide, J., Monges, G., Dérdérian, C., Seitz, J-F., and Birnbaum, D. Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br. J. Cancer, 71: 64-68, 1995.
36. Nakagawa, H., Zukerberg, L., Togawa, K., Meltzer, S. J., Nishihara, T., and Rustgi, A. K. Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer (Phila.), 76: 541-549, 1995.